We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cyclo Therapeutics Inc | NASDAQ:CYTH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 1.32% | 1.53 | 1.50 | 1.59 | 1.6199 | 1.50 | 1.56 | 32,031 | 23:00:04 |
Nevada | 001-39780 | 59-3029743 | ||
(State or other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (IRS Employer Identification No.) |
6714 NW 16th Street, Suite B, Gainesville, Florida
|
32653 |
(Address of Principal Executive Offices) | (zip code) |
386-418-8060 |
(Registrant’s telephone
number, including area code) |
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $.0001 per share
|
CYTH
|
The Nasdaq Stock Market LLC
|
Warrants to purchase Common Stock
|
CYTHW
|
The Nasdaq Stock Market LLC
|
Officer
|
Base Salary
|
Target Bonus as Percentage
of Base Salary
|
||||
N. Scott Fine (Chief Executive Officer)
|
$525,000 | 50% | ||||
Michael Lisjak (Chief Regulatory Officer)
|
$333,000 | 35% | ||||
Sharon Hrynkow (Chief Scientific Officer)
|
$323,000 | 35% | ||||
Joshua Fine (Chief Financial Officer)
|
$326,000 | 40% | ||||
Jeffrey Tate (Chief Operating Officer)
|
$300,000 | 35% |
Member
|
Chair
|
|||||
Board of Directors
|
$40,000 | $70,000 | ||||
Audit Committee
|
$7,500 | $15,000 | ||||
Compensation Committee
|
$5,500 | $11,000 | ||||
Nominating and Governance Committee
|
$4,000 | $8,000 |
(d)
|
Exhibits.
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
Cyclo Therapeutics, Inc. | |||
Date: September 1, 2021 | |||
By: | /s/ N. Scott Fine | ||
N. Scott Fine
Chief Executive Officer
|
1 Year Cyclo Therapeutics Chart |
1 Month Cyclo Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions